Skip to main content
 
  • Biosimilars

    A New Era in Medicine

    Learn More

  • Choose to be Informed

    Sign up for updates

    Learn More

  • Expanding Access and Awareness

    ...Biological Medicines

    Learn More

  • Partnership for Biosimilars Education and AccessTM

    Whether you are a community leader, health care professional, or part of an organization, there are simple ways you can make a difference.

    Get Involved

State Laws and Biosimilars

Find out about State Laws and Legislation Related to Biologic Medications and Substitution of Biosimilars

Learn more

Map Courtesy of National Conference of State Legislatures

Advances in Therapy

Awareness, Knowledge and Perceptions of Biosimilars among Specialty Physicians

Learn More

HCP Survey

Read our survey that analyzes the knowledge, awareness and perception of biosimilars among specialty physcians in the U.S.

More

Stay Connected

Get information and updates from the Biosimilars Forum

Sign Up

Educational Resources

Check out our downloadable resources

Learn More

Survey Identifies Five Major Knowledge Gaps in Biosimilars

The Biosimilars Forum conducted a survey of 1,201 U.S. specialty physicians and determined there are notable gaps in their knowledge about biosimilar concepts. The survey questioned physicians who are high prescribers of biologics, including:

  • Dermatologists
  • Gastroenterologists
  • Hematologist-oncologists
  • Medical oncologists
  • Nephrologists
  • Rheumatologists

The survey results were published in the journal, Advances in Therapy.

Learn More

About The Biosimilars Forum

The Biosimilars Forum will advance biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care. The Biosimilars Forum will provide evidence-based information to inform and support public policies that encourage access, awareness and adoption of biosimilars.

Learn More

5 Major Knowledge Gaps Identified

  • Defining biosimilars & biosimilarity 
  • Understanding extrapolation
  • Understanding the pathway 
  • Appreciating the similar safety of biosimilars and their reference products 
  • Understanding interchangability 

Learn More

Follow Us

Follow Us on Twitter